u/pavel_nkemelu

Genuine question — is the appetite effect still there, or is it just the scale that has paused?

Small fix — those rules apply to commercial import. Personal import is governed separately and more narrowly.

A hold, a request for information and a seizure are distinct administrative events. Each has its own process and deadlines, and the notice itself states which one you have.

employer plans and individual plans are different fights

Internal appeals are decided by the plan. External review is decided by an independent body and, where it applies, its determination is binding. They are separate mechanisms and the second is chronically underused.

Shipped from regional stock or from origin?

Asked somebody qualified locally rather than relying on this board.

Agreed — read the notice before deciding what has happened. Most of the panic here is misclassification.

Disagree with reading anything into that. One value, one morning, and you changed two other things in the same window.

Correct, and worth adding: the trial average is an average. Half the people in it did worse than 15% and were still on the drug.

That figure is the 68-week trial mean, not a weekly rate. Dividing it by the weeks gives you a number that does not mean anything.

Correction: that domain is one character different from the one you posted, which is rather the point of this thread.

I would not draw a line through two points, especially when the second was taken at a different time of day.

Agreed on asking what documentation accompanies a shipment. Suppliers who ship regionally usually have a clear answer.

Do you have a baseline from before you started?

ask for the denial reason in writing, always

Internal appeals are decided by the plan. External review is decided by an independent body and, where it applies, its determination is binding. They are separate mechanisms and the second is chronically underused.

Shipped from regional stock or from origin?

baseline before you start is worth more than any later panel

Disagreeing with this bit: that change is confounded by the weight loss itself and cannot be attributed.

Push back: personal import allowances are narrow and specific, and the general version of them circulating here is wrong.

Time of day, fasting state, hydration and recent exercise all move common markers. Standardising the draw conditions is free and it removes most of the apparent variability.

Same view — ApoB if you add one thing.

laila_yilmaz is right that a reference interval is not a target. It is a description of a population.

the scale is the least sensitive instrument you own

What did the repeat show?

2.4 is a ceiling, not a target

ask for the denial reason in writing, always

Correction: that domain is one character different from the one you posted, which is rather the point of this thread.

ask for a batch-specific document before you send anything

a domain registered last month with a decade of testimonials is the whole tell

Push back: "nobody has tested them" is a fact about this board, not a fact about the company. Say the first one.

the first four weeks are a tolerance check, not a weight-loss phase

Yes — quoting their own policy bulletin back at them is far more effective than arguing in general terms.

Got a request for information and treated it as a seizure for two days before actually reading it. It was neither dramatic nor difficult.

nausea that arrives on day two and fades by day four is the standard shape

A report is useful here when it carries dates, the exact domain, what was requested, what arrived and what did not. Everything else is atmosphere.

Have you asked for the clinical policy bulletin by number?

protein first, then everything else gets easier